

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.35678382 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.35678382 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.11517294 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.11517294 |
| 5 | epoxygenase P450 pathway (GO:0019373) | 7.10345356 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.53102763 |
| 7 | exogenous drug catabolic process (GO:0042738) | 6.45607397 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.27599206 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.82178793 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.82178793 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.82178793 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.72617078 |
| 13 | omega-hydroxylase P450 pathway (GO:0097267) | 5.71672014 |
| 14 | sulfur amino acid catabolic process (GO:0000098) | 5.64512687 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.63702644 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.60226786 |
| 17 | urea cycle (GO:0000050) | 5.57755297 |
| 18 | urea metabolic process (GO:0019627) | 5.57755297 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.48103677 |
| 20 | tryptophan metabolic process (GO:0006568) | 5.46712763 |
| 21 | cysteine metabolic process (GO:0006534) | 5.32673895 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.31718730 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.15065299 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 5.14522317 |
| 25 | ethanol metabolic process (GO:0006067) | 5.14435037 |
| 26 | complement activation, alternative pathway (GO:0006957) | 5.10025535 |
| 27 | protein carboxylation (GO:0018214) | 5.07553542 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.07553542 |
| 29 | regulation of plasminogen activation (GO:0010755) | 5.05764388 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 5.05562966 |
| 31 | drug metabolic process (GO:0017144) | 5.02549095 |
| 32 | regulation of protein activation cascade (GO:2000257) | 4.97504621 |
| 33 | NADH metabolic process (GO:0006734) | 4.97327421 |
| 34 | bile acid metabolic process (GO:0008206) | 4.96601102 |
| 35 | regulation of fibrinolysis (GO:0051917) | 4.94331405 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.94282853 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.84643899 |
| 38 | homocysteine metabolic process (GO:0050667) | 4.75409749 |
| 39 | regulation of cholesterol esterification (GO:0010872) | 4.75020587 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.74785261 |
| 41 | acylglycerol homeostasis (GO:0055090) | 4.73102466 |
| 42 | triglyceride homeostasis (GO:0070328) | 4.73102466 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.66642311 |
| 44 | regulation of complement activation (GO:0030449) | 4.65728589 |
| 45 | lysine metabolic process (GO:0006553) | 4.61640169 |
| 46 | lysine catabolic process (GO:0006554) | 4.61640169 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.61064671 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.61064671 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.61064671 |
| 50 | tyrosine metabolic process (GO:0006570) | 4.60144369 |
| 51 | amino-acid betaine metabolic process (GO:0006577) | 4.55889711 |
| 52 | * alpha-amino acid catabolic process (GO:1901606) | 4.51607078 |
| 53 | phospholipid efflux (GO:0033700) | 4.46918823 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.44117175 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 4.44117175 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 4.38309867 |
| 57 | cellular ketone body metabolic process (GO:0046950) | 4.23665707 |
| 58 | glycine metabolic process (GO:0006544) | 4.23431835 |
| 59 | oxaloacetate metabolic process (GO:0006107) | 4.23413281 |
| 60 | cholesterol efflux (GO:0033344) | 4.23235129 |
| 61 | coenzyme catabolic process (GO:0009109) | 4.21910939 |
| 62 | * cellular amino acid catabolic process (GO:0009063) | 4.21740590 |
| 63 | bile acid and bile salt transport (GO:0015721) | 4.21152629 |
| 64 | ethanol oxidation (GO:0006069) | 4.17310701 |
| 65 | cellular glucuronidation (GO:0052695) | 4.10794418 |
| 66 | serine family amino acid metabolic process (GO:0009069) | 4.10356730 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 4.10265253 |
| 68 | glutamate metabolic process (GO:0006536) | 4.09982949 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 4.09025248 |
| 70 | plasma lipoprotein particle assembly (GO:0034377) | 4.07822163 |
| 71 | complement activation, classical pathway (GO:0006958) | 4.07222098 |
| 72 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.03921321 |
| 73 | cellular biogenic amine catabolic process (GO:0042402) | 4.01905683 |
| 74 | amine catabolic process (GO:0009310) | 4.01905683 |
| 75 | cellular modified amino acid catabolic process (GO:0042219) | 3.98013023 |
| 76 | complement activation (GO:0006956) | 3.94325978 |
| 77 | drug catabolic process (GO:0042737) | 3.92608231 |
| 78 | benzene-containing compound metabolic process (GO:0042537) | 3.92303967 |
| 79 | acetyl-CoA metabolic process (GO:0006084) | 3.91351041 |
| 80 | creatine metabolic process (GO:0006600) | 3.90581319 |
| 81 | serine family amino acid biosynthetic process (GO:0009070) | 3.89437437 |
| 82 | intestinal cholesterol absorption (GO:0030299) | 3.88944645 |
| 83 | fructose metabolic process (GO:0006000) | 3.87371887 |
| 84 | arginine metabolic process (GO:0006525) | 3.86730007 |
| 85 | protein activation cascade (GO:0072376) | 3.85944194 |
| 86 | regulation of cholesterol homeostasis (GO:2000188) | 3.84099379 |
| 87 | cholesterol homeostasis (GO:0042632) | 3.82139519 |
| 88 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.81642065 |
| 89 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.81642065 |
| 90 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.80906546 |
| 91 | positive regulation of lipid catabolic process (GO:0050996) | 3.80609026 |
| 92 | response to mercury ion (GO:0046689) | 3.80601766 |
| 93 | low-density lipoprotein particle remodeling (GO:0034374) | 3.80066430 |
| 94 | * organic acid catabolic process (GO:0016054) | 3.76384253 |
| 95 | * carboxylic acid catabolic process (GO:0046395) | 3.76384253 |
| 96 | sterol homeostasis (GO:0055092) | 3.75587140 |
| 97 | regulation of bile acid biosynthetic process (GO:0070857) | 3.75031837 |
| 98 | short-chain fatty acid metabolic process (GO:0046459) | 3.71597804 |
| 99 | cytolysis (GO:0019835) | 3.70511093 |
| 100 | phospholipid homeostasis (GO:0055091) | 3.68906976 |
| 101 | negative regulation of lipase activity (GO:0060192) | 3.68513698 |
| 102 | protein-lipid complex assembly (GO:0065005) | 3.67038997 |
| 103 | fibrinolysis (GO:0042730) | 3.66260215 |
| 104 | ketone body metabolic process (GO:1902224) | 3.65863798 |
| 105 | fatty acid beta-oxidation (GO:0006635) | 3.64142128 |
| 106 | oxidative demethylation (GO:0070989) | 3.63878113 |
| 107 | aldehyde catabolic process (GO:0046185) | 3.62862062 |
| 108 | glucuronate metabolic process (GO:0019585) | 3.61610197 |
| 109 | uronic acid metabolic process (GO:0006063) | 3.61610197 |
| 110 | plasma lipoprotein particle organization (GO:0071827) | 3.61331089 |
| 111 | fatty acid oxidation (GO:0019395) | 3.59930032 |
| 112 | phenylpropanoid metabolic process (GO:0009698) | 3.59207769 |
| 113 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.58768875 |
| 114 | monocarboxylic acid catabolic process (GO:0072329) | 3.57576570 |
| 115 | cofactor catabolic process (GO:0051187) | 3.57541820 |
| 116 | flavonoid metabolic process (GO:0009812) | 3.56495703 |
| 117 | blood coagulation, intrinsic pathway (GO:0007597) | 3.52006054 |
| 118 | acute-phase response (GO:0006953) | 3.51330569 |
| 119 | intestinal absorption (GO:0050892) | 3.50591391 |
| 120 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.46435405 |
| 121 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.46238740 |
| 122 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.42420318 |
| 123 | negative regulation of blood coagulation (GO:0030195) | 3.41886770 |
| 124 | negative regulation of hemostasis (GO:1900047) | 3.41886770 |
| 125 | alkaloid metabolic process (GO:0009820) | 3.40139987 |
| 126 | regulation of sequestering of triglyceride (GO:0010889) | 3.38000944 |
| 127 | hormone catabolic process (GO:0042447) | 3.36050520 |
| 128 | 2-oxoglutarate metabolic process (GO:0006103) | 3.20438927 |
| 129 | diacylglycerol metabolic process (GO:0046339) | 3.15255503 |
| 130 | actin-myosin filament sliding (GO:0033275) | 3.13071357 |
| 131 | muscle filament sliding (GO:0030049) | 3.13071357 |
| 132 | primary alcohol metabolic process (GO:0034308) | 3.11614733 |
| 133 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.10908377 |
| 134 | regulation of humoral immune response (GO:0002920) | 3.09607326 |
| 135 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.09295318 |
| 136 | negative regulation of coagulation (GO:0050819) | 3.08237506 |
| 137 | proline metabolic process (GO:0006560) | 3.06334352 |
| 138 | fatty acid catabolic process (GO:0009062) | 3.03867211 |
| 139 | negative regulation of wound healing (GO:0061045) | 3.00304812 |
| 140 | primary alcohol catabolic process (GO:0034310) | 2.99799515 |
| 141 | protein-lipid complex subunit organization (GO:0071825) | 2.99148542 |
| 142 | fatty acid transmembrane transport (GO:1902001) | 2.99142457 |
| 143 | angiotensin maturation (GO:0002003) | 2.96196185 |
| 144 | carnitine shuttle (GO:0006853) | 2.95933732 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.17513555 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.02614558 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.43998244 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.32427396 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.71664679 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.24167113 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.89225328 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.03574928 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.83812873 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.48090545 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.41782988 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07381937 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.3337357 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.89215788 |
| 15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.87543560 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.71293948 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.68639573 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.64466394 |
| 19 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.51984505 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44938758 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.39111840 |
| 22 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.38150340 |
| 23 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.36863910 |
| 24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.33106918 |
| 25 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.32433237 |
| 26 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.30505128 |
| 27 | * P68_20966046_ChIP-Seq_HELA_Human | 1.30152843 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27763991 |
| 29 | SA1_27219007_Chip-Seq_Bcells_Human | 1.27285567 |
| 30 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.27042037 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21385556 |
| 32 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19223992 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18077429 |
| 34 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.16491684 |
| 35 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.16491684 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14932875 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.14796956 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.13876757 |
| 39 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.09028637 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.06432818 |
| 41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06102946 |
| 42 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05215598 |
| 43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04533895 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.03087534 |
| 45 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.02961128 |
| 46 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02704478 |
| 47 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02310516 |
| 48 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01725263 |
| 49 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.98920077 |
| 50 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98456354 |
| 51 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98153457 |
| 52 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97271672 |
| 53 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95099057 |
| 54 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.94926917 |
| 55 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.93650279 |
| 56 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93574286 |
| 57 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93403392 |
| 58 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92902221 |
| 59 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92450137 |
| 60 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92383621 |
| 61 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90941380 |
| 62 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90788453 |
| 63 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.90371348 |
| 64 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.89479771 |
| 65 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.88667629 |
| 66 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88117915 |
| 67 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.87477012 |
| 68 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.87145111 |
| 69 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87048258 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.86885111 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.86854232 |
| 72 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.86675349 |
| 73 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.86579665 |
| 74 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85230827 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84995838 |
| 76 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.84703370 |
| 77 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.84182108 |
| 78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.83905838 |
| 79 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.82974989 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81051605 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80004910 |
| 82 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.79969984 |
| 83 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.78052260 |
| 84 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.77357165 |
| 85 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.77123692 |
| 86 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.76277848 |
| 87 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.75813455 |
| 88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75191775 |
| 89 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.71575804 |
| 90 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.70110653 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69872215 |
| 92 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.68537536 |
| 93 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65902716 |
| 94 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.65309595 |
| 95 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63278087 |
| 96 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61689309 |
| 97 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.61632024 |
| 98 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.61563531 |
| 99 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.61079131 |
| 100 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.60011543 |
| 101 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.58668249 |
| 102 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57792798 |
| 103 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57401934 |
| 104 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.55282194 |
| 105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54190725 |
| 106 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.54154858 |
| 107 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.53918372 |
| 108 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52910824 |
| 109 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.52304266 |
| 110 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52024115 |
| 111 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.51414307 |
| 112 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.51201961 |
| 113 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.50745973 |
| 114 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.48960654 |
| 115 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48727848 |
| 116 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.48186293 |
| 117 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.47781742 |
| 118 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.47649325 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.47178287 |
| 120 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.47032619 |
| 121 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.47013342 |
| 122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.46914655 |
| 123 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.46914655 |
| 124 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.46718035 |
| 125 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.44498746 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.43919973 |
| 127 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43759392 |
| 128 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.42790300 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42535490 |
| 130 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.42310495 |
| 131 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.42229835 |
| 132 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.41431858 |
| 133 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.41318936 |
| 134 | * SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.41210593 |
| 135 | CBP_21632823_ChIP-Seq_H3396_Human | 0.41195449 |
| 136 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.40520838 |
| 137 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.40438675 |
| 138 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.40404118 |
| 139 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40248554 |
| 140 | AR_20517297_ChIP-Seq_VCAP_Human | 0.39697922 |
| 141 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.39681358 |
| 142 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.39303644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.02613605 |
| 2 | MP0005360_urolithiasis | 7.54365933 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.35305632 |
| 4 | MP0005365_abnormal_bile_salt | 6.17214546 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.07532492 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.13839318 |
| 7 | MP0003252_abnormal_bile_duct | 3.78233796 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.66686876 |
| 9 | MP0009840_abnormal_foam_cell | 3.34461749 |
| 10 | MP0005083_abnormal_biliary_tract | 2.95800408 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.82363930 |
| 12 | MP0005332_abnormal_amino_acid | 2.78581814 |
| 13 | MP0000751_myopathy | 2.60605586 |
| 14 | MP0003195_calcinosis | 2.54720896 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.40314509 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.21439754 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.20968056 |
| 18 | MP0000609_abnormal_liver_physiology | 2.18735263 |
| 19 | MP0003646_muscle_fatigue | 2.08636603 |
| 20 | MP0004145_abnormal_muscle_electrophysio | 1.88047470 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.83914760 |
| 22 | MP0000749_muscle_degeneration | 1.80315745 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.75830599 |
| 24 | MP0003868_abnormal_feces_composition | 1.72407106 |
| 25 | MP0001764_abnormal_homeostasis | 1.71291439 |
| 26 | MP0004036_abnormal_muscle_relaxation | 1.67697632 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55409993 |
| 28 | MP0000747_muscle_weakness | 1.47146349 |
| 29 | MP0005330_cardiomyopathy | 1.40007117 |
| 30 | MP0009697_abnormal_copulation | 1.39909953 |
| 31 | MP0005451_abnormal_body_composition | 1.38798847 |
| 32 | MP0003879_abnormal_hair_cell | 1.38741508 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.37872506 |
| 34 | MP0005670_abnormal_white_adipose | 1.32791157 |
| 35 | MP0003186_abnormal_redox_activity | 1.32036967 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.31571161 |
| 37 | MP0004087_abnormal_muscle_fiber | 1.30024960 |
| 38 | MP0004043_abnormal_pH_regulation | 1.27600557 |
| 39 | MP0004084_abnormal_cardiac_muscle | 1.25923793 |
| 40 | MP0003656_abnormal_erythrocyte_physiolo | 1.25242390 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.25119469 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.24541669 |
| 43 | MP0002332_abnormal_exercise_endurance | 1.19220945 |
| 44 | MP0003011_delayed_dark_adaptation | 1.17986864 |
| 45 | MP0000598_abnormal_liver_morphology | 1.15868324 |
| 46 | MP0010234_abnormal_vibrissa_follicle | 1.15304925 |
| 47 | MP0005647_abnormal_sex_gland | 1.14008340 |
| 48 | MP0006138_congestive_heart_failure | 1.11996798 |
| 49 | MP0002106_abnormal_muscle_physiology | 1.09991573 |
| 50 | MP0000759_abnormal_skeletal_muscle | 1.09557692 |
| 51 | MP0004130_abnormal_muscle_cell | 1.07864972 |
| 52 | MP0002254_reproductive_system_inflammat | 1.02953215 |
| 53 | MP0004147_increased_porphyrin_level | 1.02526150 |
| 54 | MP0002971_abnormal_brown_adipose | 0.98475525 |
| 55 | MP0000003_abnormal_adipose_tissue | 0.96803659 |
| 56 | MP0000604_amyloidosis | 0.95918806 |
| 57 | MP0009764_decreased_sensitivity_to | 0.95402470 |
| 58 | MP0009763_increased_sensitivity_to | 0.94773750 |
| 59 | MP0006036_abnormal_mitochondrial_physio | 0.92461939 |
| 60 | MP0005369_muscle_phenotype | 0.89996375 |
| 61 | MP0005409_darkened_coat_color | 0.89756197 |
| 62 | MP0005334_abnormal_fat_pad | 0.85791193 |
| 63 | MP0005620_abnormal_muscle_contractility | 0.85700138 |
| 64 | MP0009642_abnormal_blood_homeostasis | 0.85112331 |
| 65 | MP0002876_abnormal_thyroid_physiology | 0.84519052 |
| 66 | MP0002078_abnormal_glucose_homeostasis | 0.84053931 |
| 67 | MP0010155_abnormal_intestine_physiology | 0.83527199 |
| 68 | MP0005376_homeostasis/metabolism_phenot | 0.83178864 |
| 69 | MP0005636_abnormal_mineral_homeostasis | 0.82482354 |
| 70 | MP0002972_abnormal_cardiac_muscle | 0.82274516 |
| 71 | MP0008469_abnormal_protein_level | 0.80604048 |
| 72 | MP0005385_cardiovascular_system_phenoty | 0.79649225 |
| 73 | MP0001544_abnormal_cardiovascular_syste | 0.79649225 |
| 74 | MP0005666_abnormal_adipose_tissue | 0.79585696 |
| 75 | MP0004215_abnormal_myocardial_fiber | 0.79546803 |
| 76 | MP0005266_abnormal_metabolism | 0.77057490 |
| 77 | MP0004510_myositis | 0.76396375 |
| 78 | MP0002249_abnormal_larynx_morphology | 0.75410625 |
| 79 | MP0000678_abnormal_parathyroid_gland | 0.74852049 |
| 80 | MP0005535_abnormal_body_temperature | 0.74266065 |
| 81 | MP0010630_abnormal_cardiac_muscle | 0.74094959 |
| 82 | MP0002132_abnormal_respiratory_system | 0.72854679 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.71289878 |
| 84 | MP0005220_abnormal_exocrine_pancreas | 0.71289352 |
| 85 | MP0005448_abnormal_energy_balance | 0.71078733 |
| 86 | MP0005084_abnormal_gallbladder_morpholo | 0.70122796 |
| 87 | MP0004484_altered_response_of | 0.69961498 |
| 88 | MP0001661_extended_life_span | 0.69733062 |
| 89 | MP0003690_abnormal_glial_cell | 0.68712981 |
| 90 | MP0001765_abnormal_ion_homeostasis | 0.68233844 |
| 91 | MP0010368_abnormal_lymphatic_system | 0.67946954 |
| 92 | MP0008775_abnormal_heart_ventricle | 0.67433874 |
| 93 | MP0005408_hypopigmentation | 0.67361805 |
| 94 | MP0002837_dystrophic_cardiac_calcinosis | 0.66747344 |
| 95 | MP0000639_abnormal_adrenal_gland | 0.63534499 |
| 96 | MP0002796_impaired_skin_barrier | 0.62168653 |
| 97 | MP0004233_abnormal_muscle_weight | 0.61529426 |
| 98 | MP0009053_abnormal_anal_canal | 0.60273490 |
| 99 | MP0009115_abnormal_fat_cell | 0.60237869 |
| 100 | MP0000750_abnormal_muscle_regeneration | 0.59595039 |
| 101 | MP0003329_amyloid_beta_deposits | 0.56650124 |
| 102 | MP0001756_abnormal_urination | 0.56322597 |
| 103 | MP0001664_abnormal_digestion | 0.56191090 |
| 104 | MP0000467_abnormal_esophagus_morphology | 0.55894299 |
| 105 | MP0002127_abnormal_cardiovascular_syste | 0.55252350 |
| 106 | MP0004858_abnormal_nervous_system | 0.53657294 |
| 107 | MP0003638_abnormal_response/metabolism_ | 0.51977064 |
| 108 | MP0000579_abnormal_nail_morphology | 0.49967577 |
| 109 | MP0006035_abnormal_mitochondrial_morpho | 0.49942945 |
| 110 | MP0002970_abnormal_white_adipose | 0.49418991 |
| 111 | MP0003718_maternal_effect | 0.48529412 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.47981094 |
| 113 | MP0005395_other_phenotype | 0.47890751 |
| 114 | MP0004185_abnormal_adipocyte_glucose | 0.46706004 |
| 115 | MP0003953_abnormal_hormone_level | 0.46639301 |
| 116 | MP0008874_decreased_physiological_sensi | 0.46252834 |
| 117 | MP0005058_abnormal_lysosome_morphology | 0.44340649 |
| 118 | MP0005464_abnormal_platelet_physiology | 0.44238687 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.43456909 |
| 120 | MP0003075_altered_response_to | 0.43350414 |
| 121 | MP0002822_catalepsy | 0.42765181 |
| 122 | MP0008873_increased_physiological_sensi | 0.42665010 |
| 123 | MP0002060_abnormal_skin_morphology | 0.40175837 |
| 124 | MP0003453_abnormal_keratinocyte_physiol | 0.39248777 |
| 125 | MP0003724_increased_susceptibility_to | 0.38492648 |
| 126 | MP0005248_abnormal_Harderian_gland | 0.37725961 |
| 127 | MP0008872_abnormal_physiological_respon | 0.35733419 |
| 128 | MP0005375_adipose_tissue_phenotype | 0.34959343 |
| 129 | MP0002269_muscular_atrophy | 0.34112501 |
| 130 | MP0004264_abnormal_extraembryonic_tissu | 0.33694076 |
| 131 | MP0003959_abnormal_lean_body | 0.33172866 |
| 132 | MP0002928_abnormal_bile_duct | 0.32963453 |
| 133 | MP0003436_decreased_susceptibility_to | 0.31381262 |
| 134 | MP0000249_abnormal_blood_vessel | 0.31178743 |
| 135 | MP0005166_decreased_susceptibility_to | 0.30976054 |
| 136 | MP0009672_abnormal_birth_weight | 0.30696974 |
| 137 | MP0006082_CNS_inflammation | 0.30485436 |
| 138 | MP0002168_other_aberrant_phenotype | 0.30145089 |
| 139 | MP0001881_abnormal_mammary_gland | 0.29715411 |
| 140 | MP0001853_heart_inflammation | 0.29542928 |
| 141 | MP0001243_abnormal_dermal_layer | 0.27832486 |
| 142 | MP0004381_abnormal_hair_follicle | 0.27429847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.25894367 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.98229132 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.95129712 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.49595069 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.43448151 |
| 6 | Xanthomatosis (HP:0000991) | 6.20908812 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 6.04440259 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.48380329 |
| 9 | Complement deficiency (HP:0004431) | 5.14725346 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.84331492 |
| 11 | Hyperammonemia (HP:0001987) | 4.76273696 |
| 12 | Muscle fiber inclusion bodies (HP:0100299) | 4.55038532 |
| 13 | Epidermoid cyst (HP:0200040) | 4.51981782 |
| 14 | Exercise-induced myalgia (HP:0003738) | 4.48226503 |
| 15 | Nemaline bodies (HP:0003798) | 4.46403056 |
| 16 | Hyperglycinemia (HP:0002154) | 4.45293513 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.43998808 |
| 18 | Ketosis (HP:0001946) | 4.43638868 |
| 19 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.41859720 |
| 20 | Joint hemorrhage (HP:0005261) | 4.38901676 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.35194161 |
| 22 | Hyperglycinuria (HP:0003108) | 4.34871701 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.24081209 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 4.21241079 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 4.19762032 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.19762032 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 4.16748331 |
| 28 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.13619850 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 4.11702472 |
| 30 | Fat malabsorption (HP:0002630) | 4.09771518 |
| 31 | Hypoglycemic coma (HP:0001325) | 3.92022265 |
| 32 | Abnormality of complement system (HP:0005339) | 3.76024177 |
| 33 | Type 1 muscle fiber predominance (HP:0003803) | 3.75494662 |
| 34 | Myopathic facies (HP:0002058) | 3.70315804 |
| 35 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.67369745 |
| 36 | Hypercholesterolemia (HP:0003124) | 3.61093790 |
| 37 | Conjugated hyperbilirubinemia (HP:0002908) | 3.53962391 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.52998019 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 3.51846237 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.51617596 |
| 41 | Ketoacidosis (HP:0001993) | 3.35690393 |
| 42 | Rhabdomyolysis (HP:0003201) | 3.27412845 |
| 43 | Hyperbilirubinemia (HP:0002904) | 3.19752658 |
| 44 | Myocardial infarction (HP:0001658) | 3.12080399 |
| 45 | Hypochromic microcytic anemia (HP:0004840) | 3.07778965 |
| 46 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07468054 |
| 47 | Steatorrhea (HP:0002570) | 3.06938730 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 3.06401929 |
| 49 | Delayed CNS myelination (HP:0002188) | 3.04326812 |
| 50 | Myoglobinuria (HP:0002913) | 2.85140883 |
| 51 | Metabolic acidosis (HP:0001942) | 2.81622950 |
| 52 | Hepatocellular carcinoma (HP:0001402) | 2.80558475 |
| 53 | Skin nodule (HP:0200036) | 2.77683427 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 2.77517209 |
| 55 | Nephritis (HP:0000123) | 2.74462295 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.72298206 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.72298206 |
| 58 | Lethargy (HP:0001254) | 2.70100235 |
| 59 | Spontaneous abortion (HP:0005268) | 2.68676396 |
| 60 | Exercise-induced muscle cramps (HP:0003710) | 2.68416815 |
| 61 | Asymmetric septal hypertrophy (HP:0001670) | 2.67745726 |
| 62 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.63199408 |
| 63 | Muscle fiber splitting (HP:0003555) | 2.57987176 |
| 64 | Systemic lupus erythematosus (HP:0002725) | 2.57393782 |
| 65 | EMG: myopathic abnormalities (HP:0003458) | 2.57374679 |
| 66 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.56100724 |
| 67 | Distal lower limb muscle weakness (HP:0009053) | 2.52962406 |
| 68 | Acanthocytosis (HP:0001927) | 2.49659879 |
| 69 | Gout (HP:0001997) | 2.49252909 |
| 70 | Hyporeflexia of lower limbs (HP:0002600) | 2.48724960 |
| 71 | Vascular calcification (HP:0004934) | 2.48091386 |
| 72 | Increased connective tissue (HP:0009025) | 2.46777991 |
| 73 | Malnutrition (HP:0004395) | 2.45093474 |
| 74 | Cerebral edema (HP:0002181) | 2.43771565 |
| 75 | Spastic diplegia (HP:0001264) | 2.42962258 |
| 76 | Hypoglycemic seizures (HP:0002173) | 2.41264087 |
| 77 | Abnormal gallbladder morphology (HP:0012437) | 2.39603917 |
| 78 | Cholelithiasis (HP:0001081) | 2.35869061 |
| 79 | Irritability (HP:0000737) | 2.35713173 |
| 80 | Sudden death (HP:0001699) | 2.32730040 |
| 81 | Calf muscle hypertrophy (HP:0008981) | 2.31373236 |
| 82 | Neonatal onset (HP:0003623) | 2.26805602 |
| 83 | Neck muscle weakness (HP:0000467) | 2.24364304 |
| 84 | Pancreatitis (HP:0001733) | 2.23360855 |
| 85 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.22651992 |
| 86 | Abnormal gallbladder physiology (HP:0012438) | 2.21125586 |
| 87 | Cholecystitis (HP:0001082) | 2.21125586 |
| 88 | Cerebral palsy (HP:0100021) | 2.21077335 |
| 89 | Glomerulonephritis (HP:0000099) | 2.20839243 |
| 90 | Ileus (HP:0002595) | 2.20480618 |
| 91 | Cardiovascular calcification (HP:0011915) | 2.19640998 |
| 92 | Amyloidosis (HP:0011034) | 2.18639600 |
| 93 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.18566447 |
| 94 | Late onset (HP:0003584) | 2.18563564 |
| 95 | Hyperuricemia (HP:0002149) | 2.17383016 |
| 96 | Hydroxyprolinuria (HP:0003080) | 2.16775507 |
| 97 | Abnormality of proline metabolism (HP:0010907) | 2.16775507 |
| 98 | Brushfield spots (HP:0001088) | 2.16385264 |
| 99 | Vomiting (HP:0002013) | 2.16025596 |
| 100 | Opisthotonus (HP:0002179) | 2.15797654 |
| 101 | Esophageal varix (HP:0002040) | 2.15484369 |
| 102 | Distal lower limb amyotrophy (HP:0008944) | 2.14813765 |
| 103 | Mitral stenosis (HP:0001718) | 2.14404428 |
| 104 | Round ear (HP:0100830) | 2.14113946 |
| 105 | Muscle stiffness (HP:0003552) | 2.12691217 |
| 106 | Generalized aminoaciduria (HP:0002909) | 2.08460121 |
| 107 | Sensorimotor neuropathy (HP:0007141) | 2.07257070 |
| 108 | Abnormality of the calf musculature (HP:0001430) | 2.06429147 |
| 109 | Heart block (HP:0012722) | 2.06417793 |
| 110 | Visceral angiomatosis (HP:0100761) | 2.05968879 |
| 111 | Hemorrhage of the eye (HP:0011885) | 2.05866254 |
| 112 | Bundle branch block (HP:0011710) | 2.04827662 |
| 113 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.04257556 |
| 114 | Abnormal atrioventricular conduction (HP:0005150) | 2.03830495 |
| 115 | Atrioventricular block (HP:0001678) | 2.03607726 |
| 116 | Menorrhagia (HP:0000132) | 2.02290250 |
| 117 | Difficulty running (HP:0009046) | 2.01563108 |
| 118 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.01452842 |
| 119 | Abnormality of alanine metabolism (HP:0010916) | 2.01452842 |
| 120 | Hyperalaninemia (HP:0003348) | 2.01452842 |
| 121 | Increased variability in muscle fiber diameter (HP:0003557) | 1.99905589 |
| 122 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99682935 |
| 123 | Ventricular tachycardia (HP:0004756) | 1.99098888 |
| 124 | Poikilocytosis (HP:0004447) | 1.97529279 |
| 125 | Bulbar palsy (HP:0001283) | 1.96112893 |
| 126 | Distal arthrogryposis (HP:0005684) | 1.95445693 |
| 127 | Abnormal cartilage morphology (HP:0002763) | 1.94939497 |
| 128 | Gingival bleeding (HP:0000225) | 1.94257951 |
| 129 | Enlarged kidneys (HP:0000105) | 1.94198828 |
| 130 | Abnormality of the Achilles tendon (HP:0005109) | 1.94087166 |
| 131 | Abnormality of the gallbladder (HP:0005264) | 1.91937865 |
| 132 | Spontaneous hematomas (HP:0007420) | 1.88614264 |
| 133 | Nausea (HP:0002018) | 1.87939145 |
| 134 | Hypertriglyceridemia (HP:0002155) | 1.87493563 |
| 135 | Increased serum pyruvate (HP:0003542) | 1.87331386 |
| 136 | Thrombophlebitis (HP:0004418) | 1.86198508 |
| 137 | Acute hepatic failure (HP:0006554) | 1.85817126 |
| 138 | Turricephaly (HP:0000262) | 1.84742270 |
| 139 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83223787 |
| 140 | Abnormality of iron homeostasis (HP:0011031) | 1.82589817 |
| 141 | Rickets (HP:0002748) | 1.81951331 |
| 142 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81236253 |
| 143 | Renal cortical cysts (HP:0000803) | 1.80964108 |
| 144 | Alkalosis (HP:0001948) | 1.79688511 |
| 145 | Elevated hepatic transaminases (HP:0002910) | 1.78858487 |
| 146 | Hyperglycemia (HP:0003074) | 1.78518134 |
| 147 | Increased purine levels (HP:0004368) | 1.77231701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.86540290 |
| 2 | OBSCN | 5.01013013 |
| 3 | SIK1 | 4.63569429 |
| 4 | ERN1 | 4.03184762 |
| 5 | FGFR4 | 3.78743852 |
| 6 | TTN | 3.76526505 |
| 7 | INSRR | 2.50721728 |
| 8 | TRIB3 | 2.39510600 |
| 9 | ERBB4 | 2.29199154 |
| 10 | TAOK3 | 2.24417972 |
| 11 | MAPK15 | 2.18419097 |
| 12 | MST1R | 2.17943152 |
| 13 | PINK1 | 2.11610641 |
| 14 | ACVR1B | 2.11105977 |
| 15 | ICK | 2.09994164 |
| 16 | PIK3CA | 2.00030125 |
| 17 | MAPK11 | 1.98833187 |
| 18 | PKN2 | 1.94556322 |
| 19 | PRPF4B | 1.75221545 |
| 20 | MAP2K4 | 1.72762907 |
| 21 | FLT3 | 1.66212290 |
| 22 | MAP3K11 | 1.63606409 |
| 23 | MAP3K6 | 1.62180859 |
| 24 | EPHA2 | 1.59809955 |
| 25 | LATS1 | 1.56432027 |
| 26 | EEF2K | 1.51636998 |
| 27 | EPHB2 | 1.48962282 |
| 28 | PIK3CG | 1.45828580 |
| 29 | PRKAA2 | 1.36270394 |
| 30 | FRK | 1.34621488 |
| 31 | LMTK2 | 1.31071479 |
| 32 | TYK2 | 1.30661188 |
| 33 | PTK6 | 1.27590650 |
| 34 | MAPKAPK3 | 1.27045315 |
| 35 | CAMK1D | 1.23262317 |
| 36 | MAP3K10 | 1.21218157 |
| 37 | CSK | 1.21176554 |
| 38 | CDK6 | 1.18172167 |
| 39 | FGFR2 | 1.16737785 |
| 40 | PRKG2 | 1.16323486 |
| 41 | DYRK1B | 1.13909482 |
| 42 | ABL2 | 1.13353760 |
| 43 | JAK2 | 1.11176797 |
| 44 | MAP3K7 | 1.11135469 |
| 45 | DDR2 | 1.08123296 |
| 46 | DAPK2 | 1.05209835 |
| 47 | RIPK1 | 1.02006676 |
| 48 | MUSK | 1.01232463 |
| 49 | MAP3K1 | 0.99848462 |
| 50 | NEK9 | 0.99619513 |
| 51 | MYLK | 0.97894747 |
| 52 | KDR | 0.96380255 |
| 53 | CDC42BPA | 0.95138585 |
| 54 | PRKAA1 | 0.93530062 |
| 55 | GSK3A | 0.92847780 |
| 56 | MAPK4 | 0.92742321 |
| 57 | GRK6 | 0.91623162 |
| 58 | MAP2K3 | 0.90123499 |
| 59 | BMX | 0.87538885 |
| 60 | MET | 0.84600171 |
| 61 | TBK1 | 0.83362113 |
| 62 | PRKCZ | 0.82982808 |
| 63 | MAP3K3 | 0.81355167 |
| 64 | STK38L | 0.79113249 |
| 65 | JAK3 | 0.78430814 |
| 66 | PDGFRA | 0.78228929 |
| 67 | JAK1 | 0.77682717 |
| 68 | SMG1 | 0.77202305 |
| 69 | ERBB2 | 0.76182382 |
| 70 | CAMK2G | 0.76054144 |
| 71 | CAMK2D | 0.75996766 |
| 72 | PRKACG | 0.74606367 |
| 73 | TAOK1 | 0.73109923 |
| 74 | PDK3 | 0.72458025 |
| 75 | PDK4 | 0.72458025 |
| 76 | EPHB1 | 0.69507717 |
| 77 | SGK494 | 0.69040494 |
| 78 | SGK223 | 0.69040494 |
| 79 | MAPK12 | 0.66547309 |
| 80 | TESK1 | 0.66292832 |
| 81 | CDK9 | 0.65523880 |
| 82 | MAP4K1 | 0.65112134 |
| 83 | TIE1 | 0.61530528 |
| 84 | DMPK | 0.61218949 |
| 85 | MATK | 0.61130649 |
| 86 | TYRO3 | 0.59508561 |
| 87 | MAP3K13 | 0.59498431 |
| 88 | RPS6KB2 | 0.59253913 |
| 89 | KSR2 | 0.58144788 |
| 90 | IRAK3 | 0.57902294 |
| 91 | TRPM7 | 0.56819294 |
| 92 | ZAP70 | 0.56134284 |
| 93 | MAP2K6 | 0.56042364 |
| 94 | RPS6KC1 | 0.54001435 |
| 95 | RPS6KL1 | 0.54001435 |
| 96 | MTOR | 0.53439967 |
| 97 | TAOK2 | 0.52994406 |
| 98 | SGK3 | 0.52264687 |
| 99 | PDPK1 | 0.51470506 |
| 100 | PTK2 | 0.51196305 |
| 101 | BLK | 0.50867954 |
| 102 | CAMK1G | 0.49616397 |
| 103 | AKT3 | 0.48916293 |
| 104 | SGK2 | 0.47716502 |
| 105 | DAPK1 | 0.46981299 |
| 106 | TNK2 | 0.46100633 |
| 107 | AKT2 | 0.45895304 |
| 108 | LATS2 | 0.45718402 |
| 109 | NTRK3 | 0.45169517 |
| 110 | CAMK2B | 0.45037165 |
| 111 | FGFR3 | 0.43672329 |
| 112 | CSNK1G1 | 0.42756241 |
| 113 | PHKG1 | 0.42339211 |
| 114 | PHKG2 | 0.42339211 |
| 115 | MAP3K14 | 0.41938881 |
| 116 | CDK4 | 0.41751068 |
| 117 | RPS6KA2 | 0.41043124 |
| 118 | RPS6KA6 | 0.40533519 |
| 119 | NME1 | 0.40210483 |
| 120 | MAP2K1 | 0.40142925 |
| 121 | TGFBR2 | 0.38598491 |
| 122 | PRKG1 | 0.37631611 |
| 123 | FGR | 0.37596602 |
| 124 | PRKACA | 0.36324465 |
| 125 | MAP2K2 | 0.36041536 |
| 126 | SGK1 | 0.35896264 |
| 127 | MAPK7 | 0.35853885 |
| 128 | EGFR | 0.34893573 |
| 129 | EPHA3 | 0.34876572 |
| 130 | ROCK1 | 0.33571700 |
| 131 | MAP3K5 | 0.32803409 |
| 132 | PDK2 | 0.29447426 |
| 133 | IGF1R | 0.29074272 |
| 134 | PRKCQ | 0.28503246 |
| 135 | CSF1R | 0.27519492 |
| 136 | IKBKE | 0.27443867 |
| 137 | PRKD1 | 0.27142452 |
| 138 | PDK1 | 0.26765576 |
| 139 | MAPK3 | 0.25222701 |
| 140 | PRKD2 | 0.24467158 |
| 141 | GRK1 | 0.21843442 |
| 142 | ABL1 | 0.21653543 |
| 143 | RPS6KA1 | 0.21399926 |
| 144 | FGFR1 | 0.21104740 |
| 145 | CAMK4 | 0.21015233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.29719218 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.54402667 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.24526315 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.24497610 |
| 5 | * Arginine biosynthesis_Homo sapiens_hsa00220 | 2.88162580 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64601465 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62034194 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.58877831 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.55799386 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.52597813 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50650612 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.49924946 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27365271 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13617797 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.10387931 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08339376 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.07047774 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.02212123 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.01052458 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.91786414 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91450706 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88314531 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.87049670 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.80535140 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75984048 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70222239 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65632669 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65256614 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.60978553 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57850289 |
| 31 | * Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.54110930 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51942705 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.47567721 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47323434 |
| 35 | * 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47009244 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.45986491 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.44889530 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44538211 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43608912 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.38328201 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36798686 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36760616 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.35233375 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29051567 |
| 45 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24575668 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.20248564 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.18148116 |
| 48 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.16061587 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13416029 |
| 50 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11727861 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08121508 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03471365 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01556074 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99701477 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99357173 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93176083 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89994703 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89467938 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88783528 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85981786 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.85710087 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.75173769 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72900733 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72568757 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72186694 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63792675 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59249790 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50395326 |
| 69 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.47210974 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38263108 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36231330 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31678676 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30761450 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.29655079 |
| 75 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28577122 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28327090 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.27659931 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.27460435 |
| 79 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.24546468 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22327520 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14580994 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13053251 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.10837912 |
| 84 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.10190567 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.08760257 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.08211961 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.06973622 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.05438253 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.04320089 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.03023471 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.02463589 |
| 92 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.01626382 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2106951 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | -0.2031878 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1999523 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1988275 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1906791 |
| 98 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1906276 |
| 99 | Bladder cancer_Homo sapiens_hsa05219 | -0.1855347 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1854065 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1774920 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | -0.1615174 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1534960 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1526129 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1269718 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1172714 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1134067 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1104565 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1035401 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0213605 |
| 111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | -0.0182624 |
| 112 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0115325 |
| 113 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0097403 |
| 114 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | -0.0024688 |

